PRESS RELEASES

June 1, 2021 in Press Releases

Avails Medical’s eQUANT paper ‘Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing’ published in Scientific Reports

MENLO PARK, Calif., June 1, 2021 /PRNewswire/ – Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today the publication of a new peer-reviewed paper…
Read More
February 1, 2021 in Press Releases

Avails Medical awarded $2.5M in CARB-X funding for the development of its rapid antibiotic susceptibility testing device to identify the most effective antibiotic therapy

MENLO PARK, Calif., February 1, 2021 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today it was awarded up to $2.5M in…
Read More
March 24, 2020 in Press Releases

Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in its current equity financing round

MENLO PARK, Calif., March 24, 2020 /PRNewswire/ -- Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing (AST) for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in…
Read More
April 11, 2019 in Press Releases

Avails Medical announcing eQuant, a novel IVD being developed to allow rapid standardized inoculum generation directly from a positive blood culture

Product integrates to non-rapid commercial AST, antibiotic susceptibility test, systems and dramatically shortens the process. Menlo Park, Calif., Apr. 11th, 2019 (PRESS RELEASE) -- Avails Medical, Inc. (www.availsmedical.com), an in-vitro…
Read More

EVENTS

2021 Events Coming Soon

Scheduling for conferences in 2021.

MEDIA

Recent Posts / View All Posts

Avails has been featured on German TV

| Media | No Comments
Hightech oder Hoelle Leben im Silicon Valley Avails has been featured on German TV (VOX) documentary about the Silicon Valley